Back
Health Catalyst, Inc. Stock Predictions
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
33
HCAT
Health Catalyst, Inc.
Last Price:
$2.43
Seasonality Move:
-19.27%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atHealth Catalyst, Inc. Stock Forecast
-
Is Health Catalyst, Inc. Stock Undervalued?The current Health Catalyst, Inc. [HCAT] share price is $2.45. The Score for HCAT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
HCAT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Health Catalyst, Inc. Stock Go Up Next Year?
Data Unavailable
Health Catalyst, Inc. Stock Rating
Data Unavailable
Health Catalyst, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Technology
Sector:
Health Care
Type:
stock
Website:
healthcatalyst.com
52-Week Data
52-Week High:
7.44
52-Week Low:
2.02
Prediction Charts
Market Cap:
173.3M
Price in USD:
2.45
Volume:
442.6K
Beta:
1.33
Technical Analysis
SMA50:
2.65
SMA100:
2.85
SMA200:
3.38
52-Wk Change:
-66.71%
Stock Predictions
-
Is Health Catalyst, Inc. stock public?Yes, Health Catalyst, Inc. is a publicly traded company.
-
What is the Health Catalyst, Inc. stock quote today?The Health Catalyst, Inc. stock price is 2.45 USD today.
-
How to buy Health Catalyst, Inc. stock online?You can buy Health Catalyst, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-16 | 2.39 | 2.44 | 2.45 | 2.35 |
| Dec-17 | 2.44 | 2.39 | 2.51 | 2.37 |
| Dec-18 | 2.50 | 2.37 | 2.50 | 2.35 |
| Dec-19 | 2.36 | 2.35 | 2.39 | 2.32 |
| Dec-22 | 2.39 | 2.44 | 2.49 | 2.39 |
| Dec-24 | 2.34 | 2.38 | 2.41 | 2.33 |
| Dec-26 | 2.39 | 2.42 | 2.48 | 2.36 |
| Dec-29 | 2.40 | 2.52 | 2.54 | 2.39 |
| Dec-30 | 2.51 | 2.38 | 2.53 | 2.37 |
| Dec-31 | 2.37 | 2.39 | 2.40 | 2.34 |
| Jan-5 | 2.28 | 2.29 | 2.33 | 2.23 |
| Jan-6 | 2.28 | 2.38 | 2.39 | 2.26 |
| Jan-7 | 2.39 | 2.50 | 2.50 | 2.32 |
| Jan-8 | 2.45 | 2.45 | 2.51 | 2.44 |
Health Catalyst, Inc. Earnings
Data Unavailable
Health Catalyst, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and an increase next year of $0.11 per share.
* Health Catalyst, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.